Drug archive
Zanamivir (Inhalation—Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antiviral
Description
Zanamivir (zan-AM-e-veer)is used in the treatment of the infection caused by the flu virus (influenza A and influenza B). Zanamivir may reduce flu symptoms (weakness, headache, fever, cough, and sore throat) by 1 to 1.5 days. Zanamivir does not prevent influenza infection.
This medicine must be started within 2 days of having flu symptoms (weakness, headache, fever, cough, and sore throat). Zanamivir will not keep you from spreading the flu virus to other people. Zanamivir may not work for everybody. Zanamivir may not be for you if you are severely sick or have a breathing problem (like asthma or chronic obstructive pulmonary disease). If you receive the flu vaccine every year, continue to do so.
Brand Names
Some commonly used brand names are:
In the U.S. -
- Relenza
In Canada -
- Relenza